Post-earnings recap
Reported
Tue, Apr 23, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Amgen's earnings report shows a solid EPS beat, indicating better-than-expected profitability. However, the stock's slight decline of 0.58% suggests that investors may have been looking for more comprehensive guidance or revenue figures. The lack of revenue data and guidance could have contributed to the stock's downward movement, despite the positive EPS surprise.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.96 | N/A | +12.26% |
Overall, management conveyed a sense of cautious optimism about the company's future. They emphasized the importance of their ongoing research and development efforts.
Management highlighted strong performance in key therapeutic areas.
They acknowledged ongoing challenges in the market but expressed confidence in their pipeline.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—